妊娠相关乳腺癌诊断问题的现状
- 作者: Sadrtdinova R.F.1, Malikova E.V.2, Ponomarev A.V.3, Agzamova A.A.1, Kireev D.I.1, Ramazanova D.S.1, Amirova J.V.1, Tadzhibova Z.I.4, Ibragimov I.I.5, Akhmetova E.A.1, Kagramanyan V.R.4, Zeinalova N.A.4, Khashegulgova M.M.1
-
隶属关系:
- Bashkir State Medical University
- Rostov State Medical University
- Far Eastern Federal University
- Astrakhan State Medical University
- V.I. Vernadsky Crimean Federal University
- 期: 卷 11, 编号 4 (2024)
- 页面: 416-429
- 栏目: Reviews
- URL: https://journal-vniispk.ru/2313-8726/article/view/286421
- DOI: https://doi.org/10.17816/aog636380
- ID: 286421
如何引用文章
详细
妊娠相关乳腺癌(Pregnancy-Associated Breast Cancer, PABC)是指在怀孕期间、产后一年内或整个哺乳期首次诊断的乳腺癌。这种疾病的长期治疗过程和不良预后可能与诊断和治疗的延误有关,这些延误通常源于医生对其警惕性不足以及乳腺健康状况评估结果解释的复杂性。关于妊娠相关乳腺癌诊断的国内文献非常有限,因此对这一主题的进一步探讨显得尤为重要。
本综述旨在分析现有文献中关于妊娠相关乳腺癌诊断的研究数据。研究通过检索PubMed、eLibrary 和 Google Scholar 等电子数据库中的学术文献完成,使用的关键词和组合包括:“妊娠相关乳腺癌”,“乳腺癌”,“怀孕”,“哺乳期”,“MRI”,“CT”,“乳腺X线摄影”, “超声”,“活检”,“诊断”及其对应的英文术语。
妊娠相关乳腺癌仍是现代医学的一项重大挑战。其诊断和治疗采用多种方法,包括穿刺活检、细针穿刺活检及外科活检。超声检查在监测新辅助化疗反应及评估区域淋巴结状况方面起着重要作用。在影像学领域的进一步研究(如超声弹性成像、对比增强超声及 PET/MRI 混合技术)有望显著提高妊娠相关乳腺癌的诊断和治疗效果。对于孕期及哺乳期患者而言,无对比剂的扩散加权 MRI 在未来研究中具有特别的应用潜力。
作者简介
Ruzilya F. Sadrtdinova
Bashkir State Medical University
编辑信件的主要联系方式.
Email: sadreit@rambler.ru
ORCID iD: 0009-0004-9484-2256
Student
俄罗斯联邦, UfaElizaveta V. Malikova
Rostov State Medical University
Email: malikova1344@mail.ru
ORCID iD: 0009-0005-5051-2615
Resident
俄罗斯联邦, Rostov-on-DonAleksei V. Ponomarev
Far Eastern Federal University
Email: ponomarev.avi@dvfu.ru
ORCID iD: 0009-0000-9966-703X
Student
俄罗斯联邦, VladivostokAlina A. Agzamova
Bashkir State Medical University
Email: agzalina05@gmail.com
ORCID iD: 0009-0007-2522-6478
Student
俄罗斯联邦, UfaDaniil I. Kireev
Bashkir State Medical University
Email: daniilkireev2204@gmail.com
ORCID iD: 0009-0009-0709-0954
Student
俄罗斯联邦, UfaDaniya S. Ramazanova
Bashkir State Medical University
Email: Rrramazanova.daniya@gmail.com
ORCID iD: 0009-0002-6242-0863
Student
俄罗斯联邦, UfaJulia V. Amirova
Bashkir State Medical University
Email: Ignis2015@mail.ru
ORCID iD: 0009-0008-3872-0296
Student
俄罗斯联邦, UfaZalina I. Tadzhibova
Astrakhan State Medical University
Email: tadzhibova.z@mail.ru
ORCID iD: 0000-0001-7662-5427
Student
俄罗斯联邦, AstrakhanIlyas I. Ibragimov
V.I. Vernadsky Crimean Federal University
Email: ilyasibragimov2002@mail.ru
ORCID iD: 0000-0001-9169-5597
Student
俄罗斯联邦, SimferopolElizaveta A. Akhmetova
Bashkir State Medical University
Email: maklizi@mail.ru
ORCID iD: 0009-0004-1943-4033
Student
俄罗斯联邦, UfaVeronika R. Kagramanyan
Astrakhan State Medical University
Email: veronikakagramanyan716@gmail.com
ORCID iD: 0000-0002-6410-9000
Student
俄罗斯联邦, AstrakhanNazrin A. Zeinalova
Astrakhan State Medical University
Email: nazzzrin2424@gmail.com
ORCID iD: 0009-0009-6013-3263
Student
俄罗斯联邦, AstrakhanMadina M. Khashegulgova
Bashkir State Medical University
Email: m.khashegulgova@bk.ru
ORCID iD: 0009-0001-6408-7796
Student
俄罗斯联邦, Ufa参考
- Dobrokhotova YuE, Borovkova EI, Arutyunyan AM. Pregnancy-associated breast cancer. Russian Bulletin of Obstetrician-Gynecologist. 2019;19(4):77–81. EDN: AJBMTN doi: 10.17116/rosakush20191904177
- Hou N, Ogundiran T, Ojengbede O, et al. Risk factors for pregnancy-associated breast cancer: a report from the Nigerian breast cancer study. Ann Epidemiol. 2013;23(9):551–557. doi: 10.1016/j.annepidem. 2013.06.008
- Ayyappan AP, Kulkarni S, Crystal P. Pregnancy-associated breast cancer: spectrum of imaging appearances. Br J Radiol. 2010;83(990):529–534. doi: 10.1259/bjr/17982822
- Langer A, Mohallen M, Stevens D, et al. A single-institution study of 117 pregnancy-associated breast cancers (PABC): presentation, imaging, clinicopathological data and outcome. Diagn Interv Imaging. 2014;95(4):435–441. doi: 10.1016/j.diii.2013.12.021
- Novikova VA, Penzhoyan GA. Breast cancer and pregnancy: risks and opportunities for prevention. Gynecology. 2015;17(3):68–75. EDN: ULEAJZ
- Expert Panel on Breast Imaging, di Florio-Alexander RM, Slanetz PJ, et al. ACR Appropriateness Criteria® Breast Imaging of Pregnant and Lactating Women. J Am Coll Radiol. 2018;15(11S):S263–S275. doi: 10.1016/j.jacr.2018.09.013
- Busko EA, Semiglazov VV, Mishchenko AV, et al. The effectiveness of multiparametric ultrasound and compressive elastography in the early diagnosis of breast cancer // Diagnostic radiology and radiotherapy. 2019;(4):6–13. EDN: AQBKAB doi: 10.22328/2079-5343-2019-10-4-6-13
- Boudy AS, Zaccarini F, Selleret L, et al. Oncological management of pregnancy-associated cancers: analysis from the French CALG (Cancer Associé à La Grossesse) network. Acta Oncol. 2020;59(9):1043–1050. doi: 10.1080/0284186X.2020.1767300
- Johansson ALV, Stensheim H. Epidemiology of pregnancy-associated breast cancer. Adv Exp Med Biol. 2020;1252:75–79. doi: 10.1007/978-3-030-41596-9_9
- Matos E, Ovcaricek T. Breast cancer during pregnancy: retrospective institutional case series. Radiol Oncol. 2021; 55(3):362–368. doi: 10.2478/raon-2021-0022
- Galati F, Magri V, Arias-Cadena PA, et al. Pregnancy-associated breast cancer: a diagnostic and therapeutic challenge. Diagnostics (Basel). 2023;13(4):604. doi: 10.3390/diagnostics13040604
- Soto-Trujillo D, Santos Aragón LN, Kimura Y. Pregnancy-associated breast cancer: what radiologists must know. Cureus. 2020;12(9):e10343. doi: 10.7759/cureus.10343
- Gooch JC, Chun J, Kaplowitz E, et al. Pregnancy-associated breast cancer in a contemporary cohort of newly diagnosed women. Breast J. 2020;26(4):668–671. doi: 10.1111/tbj.13510
- Suelmann BBM, Bakhuis CFJ, van Dooijeweert C, et al. Prognosis of pregnancy-associated breast cancer: inferior outcome in patients diagnosed during second and third gestational trimesters and lactation. Breast Cancer Res Treat. 2022;192(1):175–189. doi: 10.1007/s10549-021-06471-6
- Johannsson O, Loman N, Borg A, Olsson H. Pregnancy-associated breast cancer in BRCA1 and BRCA2 germline mutation carriers. Lancet. 1998;352(9137):1359–1360. doi: 10.1016/S0140-6736(05)60750-7
- Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet. 2002;360(9328):187–195. doi: 10.1016/S0140-6736(02)09454-0
- Chernyshova AL, Chernyakov AA, Garbukov EYu, et al. Combination of pregnancy and breast cancer. Tumors of Female Reproductive System. 2023;19(3):85–91 EDN: PHPCSE doi: 10.17650/1994-4098-2023-19-3-85-91
- Reyes E, Xercavins N, Saura C, et al. Breast cancer during pregnancy: matched study of diagnostic approach, tumor characteristics, and prognostic factors. Tumori. 2020;106(5):378–387. doi: 10.1177/0300891620925158
- Reed W, Hannisdal E, Skovlund E, et al. Pregnancy and breast cancer: a population-based study. Virchows Arch. 2003;443(1):44–50. doi: 10.1007/s00428-003-0817-z
- Pavlovskaya EA, Bagnenko SS, Burovik IA, et al. Medical visualization in pregnancy: indications, limitations and prospects. Medical Visualization. 2024;28(2):95–107. EDN: CCTLVV doi: 10.24835/1607-0763-1408
- Makanjuola DI, Alkushi A, Al Anazi K. Defining radiologic complete response using a correlation of presurgical ultrasound and mammographic localization findings with pathological complete response following neoadjuvant chemotherapy in breast cancer. Eur J Radiol. 2020;130:109146. doi: 10.1016/j.ejrad.2020.109146
- Espinosa LA, Daniel BL, Vidarsson L, et al. The lactating breast: contrast-enhanced MR imaging of normal tissue and cancer. Radiology. 2005;237(2):429–436. doi: 10.1148/radiol.2372040837
- Sun J, Lee MC. Clinical presentation, diagnosis and prognosis of pregnancy-associated breast cancer. Adv Exp Med Biol. 2020;1252:87–93. doi: 10.1007/978-3-030-41596-9_11
- Zafrakas M, Papasozomenou P, Gerede A, et al. Screening and Diagnostic Mammography During Pregnancy and Lactation: A Systematic Review of the Literature. Cureus. 2024;16(8):e66465. doi: 10.7759/cureus.66465.
- Ahn BY, Kim HH, Moon WK, et al. Pregnancy- and lactation-associated breast cancer: mammographic and sonographic findings. J Ultrasound Med. 2003;22(5):491–499. doi: 10.7863/jum.2003.22.5.491
- Fazeli S, Sakala M, Rakow-Penner R, Ojeda-Fournier H. Cancer in pregnancy: breast cancer. Abdom Radiol (NY). 2023;48(5):1645–1662. doi: 10.1007/s00261-023-03824-1
- Myers KS, Green LA, Lebron L, Morris EA. Imaging appearance and clinical impact of preoperative breast MRI in pregnancy-associated breast cancer. AJR Am J Roentgenol. 2017;209(3):W177–W183. doi: 10.2214/AJR.16.17124
- Oh SW, Lim HS, Moon SM, et al. MR imaging characteristics of breast cancer diagnosed during lactation. Br J Radiol. 2017;90(1078):20170203. doi: 10.1259/bjr.20170203
- Taron J, Fleischer S, Preibsch H, et al. Background parenchymal enhancement in pregnancy-associated breast cancer: a hindrance to diagnosis? Eur Radiol. 2019;29(3):1187–1193. doi: 10.1007/s00330-018-5721-7
- Taşkın F, Polat Y, Erdoğdu İH, Soyder A. Pregnancy-associated breast cancer: A review of 47 women. Clin Imaging. 2019;58:182–186. doi: 10.1016/j.clinimag.2019.07.012
- Peterson MS, Gegios AR, Elezaby MA, et al. Breast Imaging and Intervention during Pregnancy and Lactation. Radiographics. 2023;43(10):e230014. doi: 10.1148/rg.230014
- Candelaria RP, Huang ML, Adrada BE, et al. Incremental cancer detection of locoregional restaging with diagnostic mammography combined with whole-breast and regional nodal ultrasound in women with newly diagnosed breast cancer. Acad Radiol. 2017;24(2):191–199. doi: 10.1016/j.acra.2016.11.015
- Xu K, Chung M, Hayward JH, et al. MRI of the lactating breast. Radiographics. 2024;44(2):e230129. doi: 10.1148/rg.230129
- Langer AK. Breast imaging in pregnancy and lactation. Adv Exp Med Biol. 2020;1252:17–25. doi: 10.1007/978-3-030-41596-9_3
- Pyle C, Hill M, Sharafi S, et al. Pregnancy-associated breast cancer: why breast imaging during pregnancy and lactation matters. J Breast Imaging. 2023;5(6):732–743. doi: 10.1093/jbi/wbad074
- McCormick A, Peterson E. Cancer in pregnancy. Obstet Gynecol Clin North Am. 2018;45(2):187–200. doi: 10.1016/j.ogc.2018.01.009
- Ter-Ovanesov MD, Shal EP, Kukosh MYu, Oganisyan AN. Breast cancer during pregnancy: diagnosis, treatment, prognosis. Medical Alphabet. 2018;2(29):10–16. EDN: YXDKIH
- Gradishar WJ, Moran MS, Abraham J, et al. Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2024;22(5):331–357. doi: 10.6004/jnccn.2024.0035
- Paris I, Di Giorgio D, Carbognin L, et al. Pregnancy-associated breast cancer: a multidisciplinary approach. Clin Breast Cancer. 2021;21(1):e120–e127. doi: 10.1016/j.clbc.2020.07.007
- Amant F, Deckers S, Van Calsteren K, et al. Breast cancer in pregnancy: recommendations of an international consensus meeting. Eur J Cancer. 2010;46(18):3158–3168. doi: 10.1016/j.ejca.2010.09.010
- ACR Manual on Contrast Media: ACR Committee on Drugs and Contrast Media, 2024.
- Little JT, Bookwalter CA. Magnetic resonance safety: pregnancy and lactation. Magn Reson Imaging Clin N Am. 2020;28(4):509–516. doi: 10.1016/j.mric.2020.06.002
- Alipour S. Local complications of breast surgery during pregnancy and lactation. Adv Exp Med Biol. 2020;1252:101–105. doi: 10.1007/978-3-030-41596-9_13
- Schad A, Slostad J, Rao R. Gestational breast cancer: current challenges in staging and treatment of breast cancer. BMJ Case Rep. 2020;13(11):e235308. doi: 10.1136/bcr-2020-235308
- Son EJ, Oh KK, Kim EK. Pregnancy-associated breast disease: radiologic features and diagnostic dilemmas. Yonsei Med J. 2006;47(1):34–42. doi: 10.3349/ymj.2006.47.1.34
补充文件
